Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine

Osteoporosis International

Volumn 7, Issue 3, 1997, Pages 226-230

  Kayath, M J ^a   Vieira, J G H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acromegaly; Bone mineral density; Hypogonadism; Osteoporosis

Indexed keywords

CALCIUM; GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; GIGANTISM; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; LEAN BODY WEIGHT; MALE; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPINE; SPINE DISEASE;

ACROMEGALY; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; DENSITOMETRY, X-RAY; FEMALE; GROWTH HORMONE; HUMANS; HYPOGONADISM; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; SPINAL DISEASES; TIME FACTORS;

EID: 0030974776     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01622293     Document Type: Article

References (20)

1. Avioli LV, Raisz LG. Bone metabolism and disease. In: Bondy P, Rosenberg L, editors. Metabolic control and disease. Philadelphia: WB Saunders, 1980:1709-814.
2. Bell NH, Bartter FC. Studies of Ca metabolism in acromegaly. J Clin Endocrinol Metab 1967;27:178-84.
3. Nadarajah A, Hartog M, Redfern B, et al. Calcium metabolism in acromegaly. BMJ 1968;4:797-801.
4. Diamond T, Nery L, Posen S. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 1989;111:567-73.
5. Kotzmann H, Bernecker P, Hubsch P, et al. Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 1993;8:459-65.
6. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A. A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodelling in normal human volunteers. J Bone Miner Res 1990;5:609-18.
7. Marcus R, Butterfield G, Holloway L, et al. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990;70:519-27.
8. Van der Veen EA, Netelenbos JC. Growth hormone (replacement) therapy in adults: bone and calcium metabolism. Horm Res 1990;33:65-8.
9. Stracke H, Schulz A, Moeller D, Rossol S, Schatz H. Effect of growth hormone on osteoblasts and demonstration of somatomedin-C/IGF-1 in bone organ culture. Acta Endocrinol 1984; 107:16-24.
10. Canalis E, McCarthy TL, Centrella M. The role of growth factors in skeletal remodelling. Endocrinol Metab Clin North Am 1989;18:903-18.
11. Ezzat S, Melmed S, Endres D, Exre DR, Singer FR. Biochemical assessment of bone formation and resorption in acromegaly. J Clin Endocrinol Metab 1993;76:1452-7.
12. Halloran BP, Spencer EM. Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I. Endocrinology 1988;123:1225-9.
13. Seeman E, Wahner WH, Offord KP, Kumar R, Johnson WJ, Riggs BL. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest 1982;69:1302-9.
14. Vieira JHG, Lombardi MT, Nishida SK. Monoclonal antibody-based immunoenzymometric assay for serum human growth hormone. Braz Med Biol Res 1990;23:293-6.
15. Furlaneto RW, Underwood LE, Van Wyk JJ, D'Ercole AJ. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 1977; 60:648-51.
16. Filkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF, Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987;106: 354-61.
17. Bouillon R. Growth hormone and bone. Horm Res 1991;36:49-55.
18. De la Piedra C, Larranaga ECJ, Castro N, Horcajada C, Rapado A, Herrera Pombo JL. Correlation among plasma osteocalcin, growth hormone and somatomedin C in acromegaly. Calcif Tissue Int 1988;43:44-5.
19. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachmann M, Christiansen C. Serum bone GIa protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. J Clin Endocrinol Metab 1990;71:122-6.
20. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe MR. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocnnol Metab 1992;74.118-23.